14/11/2025
𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗖𝗼𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗔𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁 𝗕𝗲𝘁𝘄𝗲𝗲𝗻 𝗠𝗶𝗻𝗮𝗽𝗵𝗮𝗿𝗺 𝗮𝗻𝗱 𝗕𝗮𝘆𝗲𝗿 𝘁𝗼 𝗟𝗼𝗰𝗮𝗹𝗶𝘇𝗲 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗶𝗻 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗮𝗻𝗱 𝗙𝗮𝗺𝗶𝗹𝘆 𝗣𝗹𝗮𝗻𝗻𝗶𝗻𝗴
Minapharm Pharmaceuticals and Bayer AG have signed a strategic collaboration agreement to Localize Pharmaceutical Manufacturing in Women's Health and Family Planning for local and African markets
The collaboration strengthens Egypt’s national priorities by promoting local manufacturing, advancing women’s health and directly supporting Egypt’s National Population and Development Strategy. It further contributes to expanding the country’s pharmaceutical export capacity across Africa, reinforcing Egypt’s position as a regional hub for medicines production.
This key milestone builds on Minapharm’s long-standing expertise in technology transfer and global partnerships, reinforcing its position as a pioneering industrial platform capable of supporting national health priorities and expanding export to regional and African markets.
The agreement was signed on the sidelines of the Global Population Health Development Congress (GPHDC), in the presence of His Excellency Dr. Khaled Abdel Ghaffar, Deputy Prime Minister for Human Development and Minister of Health and Population, Dr. Mohamed Awad Tag El-Din, Presidential Advisor for Health and Prevention Affairs, Dr. Ali El-Ghamrawy, Chairperson of the Egyptian Drug Authority (EDA), and Dr. Hisham Stait, Chairman of the Unified Procurement Authority (UPA).
